Avalon Ventures Xi, L.p. - Net Worth and Insider Trading
Avalon Ventures Xi, L.p. Net Worth
The estimated net worth of Avalon Ventures Xi, L.p. is at least $407 Million dollars as of 2024-11-05. Avalon Ventures Xi, L.p. is the 10% Owner of Janux Therapeutics Inc and owns about 7,377,765 shares of Janux Therapeutics Inc (JANX) stock worth over $407 Million. Details can be seen in Avalon Ventures Xi, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Avalon Ventures Xi, L.p. has not made any transactions after 2024-10-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Avalon Ventures Xi, L.p.
Avalon Ventures Xi, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Avalon Ventures Xi, L.p. owns 1 companies in total, including Janux Therapeutics Inc (JANX) .
Click here to see the complete history of Avalon Ventures Xi, L.p.’s form 4 insider trades.
Insider Ownership Summary of Avalon Ventures Xi, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| JANX | Janux Therapeutics Inc | 2024-10-18 | 10 percent owner |
Avalon Ventures Xi, L.p. Latest Holdings Summary
Avalon Ventures Xi, L.p. currently owns a total of 1 stock. Avalon Ventures Xi, L.p. owns 7,377,765 shares of Janux Therapeutics Inc (JANX) as of October 18, 2024, with a value of $407 Million.
Latest Holdings of Avalon Ventures Xi, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| JANX | Janux Therapeutics Inc | 2024-10-18 | 7,377,765 | 55.12 | 406,662,407 |
Holding Weightings of Avalon Ventures Xi, L.p.
Avalon Ventures Xi, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Avalon Ventures Xi, L.p. has made a total of 6 transactions in Janux Therapeutics Inc (JANX) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in Janux Therapeutics Inc is the sale of 1,673,128 shares on October 18, 2024, which brought Avalon Ventures Xi, L.p. around $77 Million.
Insider Trading History of Avalon Ventures Xi, L.p.
- 1
Avalon Ventures Xi, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Avalon Ventures Xi, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Avalon Ventures Xi, L.p. is 11.85%. GuruFocus also compares Avalon Ventures Xi, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Avalon Ventures Xi, L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Avalon Ventures Xi, L.p.'s insider trading performs compared to the benchmark.
Performance of Avalon Ventures Xi, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 42.74 |  | | | | |
| Relative Return to S&P 500(%) | 36.04 | | | | | |
Avalon Ventures Xi, L.p. Ownership Network
Ownership Network List of Avalon Ventures Xi, L.p.
Ownership Network Relation of Avalon Ventures Xi, L.p.
Avalon Ventures Xi, L.p. Owned Company Details
What does Janux Therapeutics Inc do?
Who are the key executives at Janux Therapeutics Inc?
Avalon Ventures Xi, L.p. is the 10 percent owner of Janux Therapeutics Inc. Other key executives at Janux Therapeutics Inc include director & Chief Executive Officer David Alan Campbell , director & 10 percent owner Ra Capital Healthcare Fund Lp , and Chief Business Officer Andrew Hollman Meyer .
Janux Therapeutics Inc (JANX) Insider Trades Summary
Over the past 18 months, Avalon Ventures Xi, L.p. made 6 insider transaction in Janux Therapeutics Inc (JANX) with a net sale of 3,324,326. Other recent insider transactions involving Janux Therapeutics Inc (JANX) include a net sale of 653,961 shares made by Jay Lichter , a net purchase of 1,695,008 shares made by Ra Capital Healthcare Fund Lp , and a net sale of 50,000 shares made by David Alan Campbell .
In summary, during the past 3 months, insiders sold 2,782,995 shares of Janux Therapeutics Inc (JANX) in total and bought 1,200,000 shares, with a net sale of 1,582,995 shares. During the past 18 months, 6,605,716 shares of Janux Therapeutics Inc (JANX) were sold and 4,244,570 shares were bought by its insiders, resulting in a net sale of 2,361,146 shares.
Janux Therapeutics Inc (JANX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Janux Therapeutics Inc Insider Transactions
Avalon Ventures Xi, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Avalon Ventures Xi, L.p.. You might contact Avalon Ventures Xi, L.p. via mailing address: 1134 Kline Street, La Jolla Ca 92037.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
